We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Clinical Trials Begin Using Radiopaque Microscopic Beads

By MedImaging International staff writers
Posted on 17 Oct 2017
Researchers in the US have begun clinical trials of a new experimental cancer treatment that makes use of microscopic beads loaded with a targeted cancer drug, that are visible on a Computed Tomography (CT) scan.

The goal of the Vandetanib-Eluting Radiopaque Beads in Patients with Resectable Liver Malignancies (VEROnA) trial is to evaluate delivering a precisely controlled dose of the drug into the arteries that feed a liver tumor, and to improve treatments for metastatic Colorectal Cancer (mCRC), and primary-liver cancer patients.

The technique was developed by researchers from the University College London Cancer Institute (UCL; London, UK), and BTG (London, UK), a specialist healthcare company, and is intended for treating liver-cancer patients. The technique makes use of microscopic radiopaque beads loaded with a targeted anti-cancer drug called vandetanib, which are placed directly into the liver.

Primary investigator of the study, professor Ricky Sharma, at University College London, said, "The incidence and mortality rates for primary liver cancer continue to climb and it is vital that we explore new treatment approaches. This research is exciting because it is the first time we have been able to pre-load a targeted cancer drug on to an imageable bead, to deliver the targeted drug in high doses to the cancer and see exactly how well the beads reach the target we have defined. By refining the treatment using information from this clinical trial, we may be able to develop a liver-directed treatment as a superior alternative to the rather poorly tolerated drug treatments we currently offer patients with this type of cancer."

Related Links:
University College London Cancer Institute
BTG

Digital X-Ray Detector Panel
Acuity G4
Computed Tomography System
Aquilion ONE / INSIGHT Edition
X-ray Diagnostic System
FDX Visionary-A
Multi-Use Ultrasound Table
Clinton

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.